Daiken Biomedical Co., Ltd. (TPE:7780)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
24.20
-0.20 (-0.82%)
At close: Feb 11, 2026
Market Cap19.60B +84.6%
Revenue (ttm)1.78B +42.7%
Net Income268.63M +116.5%
EPS0.44 +21.6%
Shares Out810.02M
PE Ratio55.39
Forward PE46.01
Dividend0.40 (1.67%)
Ex-Dividend DateNov 24, 2025
Volume4,776,316
Average Volume16,119,930
Open24.40
Previous Close24.40
Day's Range24.00 - 24.50
52-Week Range14.65 - 40.10
Betan/a
RSI52.14
Earnings DateApr 23, 2026

About Daiken Biomedical

Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. is a subsidiary of Sunfun Info Co., Ltd. [Read more]

Employees 20
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 7780
Full Company Profile

Financial Performance

In 2024, Daiken Biomedical's revenue was 1.36 billion, an increase of 14.45% compared to the previous year's 1.19 billion. Earnings were 106.58 million, a decrease of -33.54%.

Financial Statements